SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-002918
Filing Date
2021-06-10
Accepted
2021-06-10 17:06:02
Documents
1
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 form4-06102021_050633.html 4  
1 form4-06102021_050633.xml 4 4385
  Complete submission text file 0001415889-21-002918.txt   5843
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Goldberg Mark Alan (Reporting) CIK: 0001532475 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 211008867